These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 17656824)
21. CD36 mediates the innate host response to beta-amyloid. El Khoury JB; Moore KJ; Means TK; Leung J; Terada K; Toft M; Freeman MW; Luster AD J Exp Med; 2003 Jun; 197(12):1657-66. PubMed ID: 12796468 [TBL] [Abstract][Full Text] [Related]
22. Innate immunity in Alzheimer's disease: a complex affair. Guillot-Sestier MV; Town T CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):593-607. PubMed ID: 23574177 [TBL] [Abstract][Full Text] [Related]
23. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. Fassbender K; Walter S; Kühl S; Landmann R; Ishii K; Bertsch T; Stalder AK; Muehlhauser F; Liu Y; Ulmer AJ; Rivest S; Lentschat A; Gulbins E; Jucker M; Staufenbiel M; Brechtel K; Walter J; Multhaup G; Penke B; Adachi Y; Hartmann T; Beyreuther K FASEB J; 2004 Jan; 18(1):203-5. PubMed ID: 14597556 [TBL] [Abstract][Full Text] [Related]
24. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
25. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes. Walker DG; Link J; Lue LF; Dalsing-Hernandez JE; Boyes BE J Leukoc Biol; 2006 Mar; 79(3):596-610. PubMed ID: 16365156 [TBL] [Abstract][Full Text] [Related]
26. Role of the peripheral innate immune system in the development of Alzheimer's disease. Le Page A; Dupuis G; Frost EH; Larbi A; Pawelec G; Witkowski JM; Fulop T Exp Gerontol; 2018 Jul; 107():59-66. PubMed ID: 29275160 [TBL] [Abstract][Full Text] [Related]
27. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q. Webster SD; Galvan MD; Ferran E; Garzon-Rodriguez W; Glabe CG; Tenner AJ J Immunol; 2001 Jun; 166(12):7496-503. PubMed ID: 11390503 [TBL] [Abstract][Full Text] [Related]
29. Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophages. Mizwicki MT; Menegaz D; Zhang J; Barrientos-Durán A; Tse S; Cashman JR; Griffin PR; Fiala M J Alzheimers Dis; 2012; 29(1):51-62. PubMed ID: 22207005 [TBL] [Abstract][Full Text] [Related]
30. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease. Simard AR; Rivest S Mol Psychiatry; 2006 Apr; 11(4):327-35. PubMed ID: 16491130 [TBL] [Abstract][Full Text] [Related]
31. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Fiala M; Liu PT; Espinosa-Jeffrey A; Rosenthal MJ; Bernard G; Ringman JM; Sayre J; Zhang L; Zaghi J; Dejbakhsh S; Chiang B; Hui J; Mahanian M; Baghaee A; Hong P; Cashman J Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12849-54. PubMed ID: 17652175 [TBL] [Abstract][Full Text] [Related]
32. Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease. Liu H; Zhou YC; Song W Int Immunopharmacol; 2021 Dec; 101(Pt A):108263. PubMed ID: 34710847 [TBL] [Abstract][Full Text] [Related]
33. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice. Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784 [TBL] [Abstract][Full Text] [Related]
35. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347 [TBL] [Abstract][Full Text] [Related]
36. Complex regulation of acute and chronic neuroinflammatory responses in mouse models deficient for nuclear factor kappa B p50 subunit. Rolova T; Puli L; Magga J; Dhungana H; Kanninen K; Wojciehowski S; Salminen A; Tanila H; Koistinaho J; Malm T Neurobiol Dis; 2014 Apr; 64():16-29. PubMed ID: 24345324 [TBL] [Abstract][Full Text] [Related]
37. Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer's Disease. Tamburini B; Badami GD; La Manna MP; Shekarkar Azgomi M; Caccamo N; Dieli F Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569296 [TBL] [Abstract][Full Text] [Related]
38. The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications. Rozemuller AJ; van Gool WA; Eikelenboom P Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):223-33. PubMed ID: 15975026 [TBL] [Abstract][Full Text] [Related]
39. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies. Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154 [TBL] [Abstract][Full Text] [Related]
40. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease. Blasko I; Grubeck-Loebenstein B Drugs Aging; 2003; 20(2):101-13. PubMed ID: 12534311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]